Debiopharm Group

Debiopharm Group

Debiopharm Group


Chemin Messidor 5-7 Case postale 5911 Lausanne, Vaud, CH - 1002, Switzerland

Type of Company


Employees (Worldwide)

501 - 1,000


Medical Support Services

Company Description

Debiopharm Groupâ„¢ is a global biopharmaceutical development specialist that in-licenses promising biologics and small molecule drug candidates. They develop their products for global registration and maximum commercial potential for out-licensing to pharmaceutical partners for sales and marketing.

Contact Data
Trying to get in touch with decision makers at Debiopharm Group? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

Co-President & Founder

Communication Coordinator

Communication Coordinator

Consultant-Press & Public Relations Officer

Director-Human Resources

Vice President-Corporate Development

Vice President of the Project & Portfolio Management Office

Board of Directors

President at Debiopharm Group

Paths to Debiopharm Group
Potential Connections via
Relationship Science
Debiopharm Group
Details Hidden

Diagnoplex SA develops molecular diagnostics for colon cancer. It lead product, Colox is a minimally-invasive blood test developed for the systematic screening and detection of early and advanced colorectal cancer. The company was founded in April 2005 by Stavros Therianos, Curzio Roberto Maria Rüegg, Jacques R. Essinger and Jean-Pierre Rosat and is headquartered in Lausanne, Switzerland.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Debiopharm Group. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Debiopharm Group's profile does not indicate a business or promotional relationship of any kind between RelSci and Debiopharm Group.
  • be_ixf; php_sdk; php_sdk_1.4.15